Novavax (United States)

Novavax (United States)

Novavax, Inc., based in Gaithersburg, Maryland, develops vaccines to counter infectious diseases. The company developed the Novavax COVID-19 vaccine, now commercialized by Sanofi. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Novavax (United States), United States, covering academic research published from 2000 to 2025. Read More.


Open Access Percentage

85%


Total
Publications

381


Total Open
Publications

323


Total
Citations

15K


Open Access
Percentage

85%


Total
Publications

381


Total Open
Publications

323


Total
Citations

15K

Wikipedia

Website

download

Breakdown

17% 42% 26% 15%

Publisher Open

17%

Both

42%

Other Platform Open

26%

Closed

15%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
20002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

051015202530354045505560Total Publications
20002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025

Open

Closed

Publisher Open

54%OA Journal

OA Journal 54%

121

Hybrid 30%

67

No Guarantees 16%

37

Other Platform Open

Domain 67%

173

Institution 38%

98

Preprint 26%

66

Other Internet 8%

21

Public 4%

10

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
177
doaj.org OAI-PMH Repository
Institution
55
medRxiv
Preprint
40
DOI
Other Internet
19
bioRxiv
Preprint
18
Europe PMC
Domain
10
University of Oxford
Institution
7
Figshare
Public
7
University of Groningen
Institution
6
Royal Netherlands Academy of Arts and Sciences
Institution
6
1 / 6

Data updated 12 August 2026

Share

Share

Share